| First Author | Rheault MN | Year | 2004 |
| Journal | J Am Soc Nephrol | Volume | 15 |
| Issue | 6 | Pages | 1466-74 |
| PubMed ID | 15153557 | Mgi Jnum | J:102306 |
| Mgi Id | MGI:3607348 | Doi | 10.1097/01.asn.0000130562.90255.8f |
| Citation | Rheault MN, et al. (2004) Mouse model of X-linked Alport syndrome. J Am Soc Nephrol 15(6):1466-74 |
| abstractText | X-linked Alport syndrome (XLAS) is a progressive disorder of basement membranes caused by mutations in the COL4A5 gene, encoding the alpha5 chain of type IV collagen. A mouse model of this disorder was generated by targeting a human nonsense mutation, G5X, to the mouse Col4a5 gene. As predicted for a nonsense mutation, hemizygous mutant male mice are null and heterozygous carrier female mice are mosaic for alpha5(IV) chain expression. Mutant male mice and carrier female mice are viable through reproductive age and fertile. Mutant male mice died spontaneously at 6 to 34 wk of age, and carrier female mice died at 8 to 45 wk of age, manifesting proteinuria, azotemia, and progressive and manifold histologic abnormalities of the kidney glomerulus and tubulointerstitium. Ultrastructural abnormalities of the glomerular basement membrane, including lamellation and splitting, were characteristic of human XLAS. The mouse model described here recapitulates essential clinical and pathologic findings of human XLAS. With alpha5(IV) expression reflecting X-inactivation patterns, it will be especially useful in studying determinants of disease variability in the carrier state. |
